Atlas Trials

Safety, Tolerability and Pharmacokinetic Study of LTI-03 in Healthy Adult Subjects

Clinical trial NCT04233814 · COMPLETED

Trial details

NCT number
NCT04233814
Sponsor
Rein Therapeutics
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Idiopathic Pulmonary Fibrosis
Start date
2020-01-20
Primary completion
2021-12-23
Enrollment
71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.